BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,193,465 | +752.1% | 4,221,000 | +786.8% | 0.04% | +775.0% |
| Q3 2021 | $492,135 | -85.3% | 476,000 | -85.2% | 0.00% | -89.2% |
| Q3 2020 | $3,350,000 | +11864.3% | 3,207,000 | +13843.5% | 0.04% | – |
| Q2 2020 | $28,000 | +21.7% | 23,000 | +4.5% | 0.00% | – |
| Q1 2020 | $23,000 | -80.8% | 22,000 | -80.7% | 0.00% | -100.0% |
| Q4 2019 | $120,000 | -71.2% | 114,000 | -71.4% | 0.00% | -66.7% |
| Q2 2019 | $416,000 | -87.0% | 398,000 | -88.3% | 0.00% | -82.4% |
| Q1 2018 | $3,209,000 | -6.4% | 3,400,000 | -0.9% | 0.02% | +6.2% |
| Q4 2017 | $3,427,000 | – | 3,430,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
| SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
| SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
| PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
| RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
| Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
| Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
| MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
| Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |